default author photo

Deepak Kumar

Bharat Biotech International Ltd

India

SCHOLARLY PAPERS

1

DOWNLOADS

60

TOTAL CITATIONS

5

Scholarly Papers (1)

Actions:
Email selected abstracts
1.

Evaluation of Safety and Immunogenicity of an Adjuvanted, TH-1 Skewed, Whole Virion Inactivated SARS-CoV-2 Vaccine - BBV152

Number of pages: 45 Posted: 25 Nov 2020
Brunda Ganneru, Harsh Jogdand, Vijaya Kumar Daram, Narasimha Reddy Molugu, Sai D. Prasad, Srinivas V. Kannappa, Krishna M. Ella, Rajaram Ravikrishnan, Amit Awasthi, Jomy Jose, Panduranga Rao, Deepak Kumar, Raches Ella, Priya Abraham, Pragya Yadav, Gajanan N. Sapkal, Anita Shete, Gururaj Rao Desphande, Sreelekshmy Mohandas, Atanu Basu, Nivedita Gupta and Krishna Mohan Vadrevu
Bharat Biotech International Ltd, Bharat Biotech International Ltd, Bharat Biotech International Ltd, Bharat Biotech International Ltd, Bharat Biotech International Ltd, Bharat Biotech International Ltd, Bharat Biotech International Ltd, RCC Labs, Government of India - Immuno-biology Lab, RCC Labs, Bharat Biotech International Ltd, Bharat Biotech International Ltd, Bharat Biotech International Ltd, National Institute of Virology-Indian Council of Medical Research (NIV-ICMR), National Institute of Virology-Indian Council of Medical Research (NIV-ICMR), National Institute of Virology-Indian Council of Medical Research (NIV-ICMR), National Institute of Virology-Indian Council of Medical Research (NIV-ICMR), National Institute of Virology-Indian Council of Medical Research (NIV-ICMR), National Institute of Virology-Indian Council of Medical Research (NIV-ICMR), National Institute of Virology-Indian Council of Medical Research (NIV-ICMR), Indian Council of Medical Research (ICMR) and Bharat Biotech International Ltd
Downloads 60 (961,006)
Citation 5

Abstract:

Loading...

SARS-CoV-2; covid vaccine; COVID-19; covaxin; BBV152